Scientific paper - Original scientific paper
Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis
Disease Markers, 2022 (2022); 4433313,. https://doi.org/10.1155/2022/4433313


Cite this document

Bursać, I. U., Kehler, T., Drvar, V., Babarović, E., Pejčinović, V. P., Baršić, A. R. ... Laškarin, G. (2022). Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis. Disease Markers, 2022.. doi: 10.1155/2022/4433313

Bursać, Iva Uravić, et al. "Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis." Disease Markers, vol. 2022, 2022. https://doi.org/10.1155/2022/4433313

Bursać, Iva Uravić, Tatjana Kehler, Vedrana Drvar, Emina Babarović, Vesna Pehar Pejčinović, Antonija Ružić Baršić, Viktor Peršić and Gordana Laškarin. "Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis." Disease Markers 2022 (2022). https://doi.org/10.1155/2022/4433313

Bursać, I. U., et al. (2022) 'Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis', Disease Markers, 2022. doi: 10.1155/2022/4433313

Bursać IU, Kehler T, Drvar V, Babarović E, Pejčinović VP, Baršić AR, and sur.. Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis. Disease Markers [Internet]. 2022 [cited 2024 July 08];2022. doi: 10.1155/2022/4433313

I. U. Bursać, et al., "Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis", Disease Markers, vol. 2022, 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:173782. [Accessed: 08 July 2024]

Please login to the repository to save this object to your list.